Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06707688 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Abbott Medical - VERITAS Study

StatusActive, Not Recruiting
PhaseNot applicable
Started2024-11-07
View on ClinicalTrials.gov ↗

Amendment history

2026-08-03
Study Status v15
Re-verified, no change to tracked fields
2026-06-02
Study Status, Contacts/Locations v14
Study sitesdetails revised at 1 of 35 sites
2026-02-17
Study Status, Contacts/Locations v13
Primary completion date2025-11-04→2025-11-06
Start date2024-11-11→2024-11-07
Study sitesdetails revised at 1 of 35 sites
2025-12-18
Study Status, Contacts/Locations v12
Study sites36→35
2025-12-04
Study Status, Oversight, Contacts/Locations v11
Primary completion dateestimated 2025-10→confirmed 2025-11-04
Study sites37→36
Show 10 earlier versions
2025-10-06
Study Status, Oversight, Contacts/Locations v10
Study sites37 entries, revised
Henry Ford Providence Southfield Hospital Mount Sinai Hospital Baylor Scott & White All Saints Medical Center Baylor atScott Fort& Worth White - The Heart Hospital Baylor Plano
2025-09-18
Recruiting→Active, Not Recruiting Study Status, Study Design, Contacts/Locations v9
Trial statusRecruiting→Active, Not Recruiting
Primary completion date2026-07→2025-10
Completion date2028-07→2027-09
Enrollment targetestimated 475→confirmed 458
Study sites38→37
2025-08-05
Study Status, Contacts/Locations v8
Study sites39→38
2025-07-08
Study Status, Oversight, Contacts/Locations v7
Study sitesdetails revised at 12 of 39 sites
2025-06-06
Study Status, Contacts/Locations v6
Study sites40→39
2025-05-09
Study Status, Contacts/Locations v5
Study sitesdetails revised at 40 of 40 sites
2025-04-08
Study Status, Contacts/Locations v4
Study sitesdetails revised at 9 of 40 sites
2025-03-06
Study Status, Contacts/Locations v3
Study sitesdetails revised at 7 of 40 sites
2025-01-22
Study Status, Contacts/Locations v2
Study sites40 entries, revised
NewNYU YorkLangone University HospitalHealth
2024-12-19
Study Status, Oversight, Contacts/Locations v1
Study sites39→40
2024-11-25
Original filing
The primary objective of this study is to evaluate the safety and effectiveness of Abbott's Amulet™ 2 Left Atrial Appendage (LAA) occluder device (Amulet 2 device) in patients who have non-valvular atrial fibrillation and who are at increased risk for stroke and systemic embolism and have appropriate rationale to seek a non-pharmacologic alternative to oral anticoagulation.
Trial Details
NCT Number NCT06707688
Lead Sponsor Abbott Medical Devices
Conditions Atrial Fibrillation (AF), Stoke
Enrollment 458 participants
Start Date 2024-11-07
Primary Completion 2025-11-06 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2026-08-04